Dysregulation of ubiquitination modification in renal cell carcinoma

Renal cell carcinoma (RCC) is a malignant tumor of the renal tubular epithelial cells with a relatively high incidence rate worldwide. A large number of studies have indicated that dysregulation of the ubiquitination, including ubiquitination and dysregulation, is associated with the occurrence and...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongjie You, Hui Zhang, Xiaofeng Jin, Zejun Yan
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2024.1453191/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846116350513119232
author Hongjie You
Hui Zhang
Xiaofeng Jin
Zejun Yan
author_facet Hongjie You
Hui Zhang
Xiaofeng Jin
Zejun Yan
author_sort Hongjie You
collection DOAJ
description Renal cell carcinoma (RCC) is a malignant tumor of the renal tubular epithelial cells with a relatively high incidence rate worldwide. A large number of studies have indicated that dysregulation of the ubiquitination, including ubiquitination and dysregulation, is associated with the occurrence and development of RCC. This review focuses on several abnormal signaling pathways caused by E3 ligases and deubiquitinases. Additionally, we discuss research progress in RCC treatment by targeting key enzymes related to ubiquitination modifications.
format Article
id doaj-art-d0cc33e4fea540a5b983204a6adf9ec4
institution Kabale University
issn 1664-8021
language English
publishDate 2024-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj-art-d0cc33e4fea540a5b983204a6adf9ec42024-12-19T06:24:07ZengFrontiers Media S.A.Frontiers in Genetics1664-80212024-12-011510.3389/fgene.2024.14531911453191Dysregulation of ubiquitination modification in renal cell carcinomaHongjie YouHui ZhangXiaofeng JinZejun YanRenal cell carcinoma (RCC) is a malignant tumor of the renal tubular epithelial cells with a relatively high incidence rate worldwide. A large number of studies have indicated that dysregulation of the ubiquitination, including ubiquitination and dysregulation, is associated with the occurrence and development of RCC. This review focuses on several abnormal signaling pathways caused by E3 ligases and deubiquitinases. Additionally, we discuss research progress in RCC treatment by targeting key enzymes related to ubiquitination modifications.https://www.frontiersin.org/articles/10.3389/fgene.2024.1453191/fullE3 ubiquitin ligasesrenal cell carcinoma (RCC)ubiquitinationPROTACimmunotherapydeubiquitinase
spellingShingle Hongjie You
Hui Zhang
Xiaofeng Jin
Zejun Yan
Dysregulation of ubiquitination modification in renal cell carcinoma
Frontiers in Genetics
E3 ubiquitin ligases
renal cell carcinoma (RCC)
ubiquitination
PROTAC
immunotherapy
deubiquitinase
title Dysregulation of ubiquitination modification in renal cell carcinoma
title_full Dysregulation of ubiquitination modification in renal cell carcinoma
title_fullStr Dysregulation of ubiquitination modification in renal cell carcinoma
title_full_unstemmed Dysregulation of ubiquitination modification in renal cell carcinoma
title_short Dysregulation of ubiquitination modification in renal cell carcinoma
title_sort dysregulation of ubiquitination modification in renal cell carcinoma
topic E3 ubiquitin ligases
renal cell carcinoma (RCC)
ubiquitination
PROTAC
immunotherapy
deubiquitinase
url https://www.frontiersin.org/articles/10.3389/fgene.2024.1453191/full
work_keys_str_mv AT hongjieyou dysregulationofubiquitinationmodificationinrenalcellcarcinoma
AT huizhang dysregulationofubiquitinationmodificationinrenalcellcarcinoma
AT xiaofengjin dysregulationofubiquitinationmodificationinrenalcellcarcinoma
AT zejunyan dysregulationofubiquitinationmodificationinrenalcellcarcinoma